HomeADMA • NASDAQ
add
ADMA Biologics Inc
Previous close
$9.06
Day range
$8.91 - $9.31
Year range
$3.06 - $9.33
Market cap
2.13B USD
Avg Volume
2.69M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 81.88M | 43.86% |
Operating expense | 17.29M | -0.23% |
Net income | 17.81M | 362.28% |
Net profit margin | 21.75 | 282.31% |
Earnings per share | 0.08 | 366.67% |
EBITDA | 23.94M | 1,861.89% |
Effective tax rate | 3.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.32M | -34.51% |
Total assets | 350.88M | 2.96% |
Total liabilities | 197.17M | 1.04% |
Total equity | 153.71M | — |
Shares outstanding | 231.81M | — |
Price to book | 13.73 | — |
Return on assets | 16.04% | — |
Return on capital | 19.08% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 17.81M | 362.28% |
Cash from operations | -2.22M | 84.94% |
Cash from investing | -2.36M | -21.44% |
Cash from financing | -1.45M | -122.62% |
Net change in cash | -6.03M | 65.20% |
Free cash flow | -8.77M | 45.98% |
About
Founded
2004
Headquarters
Website
Employees
624
